Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stocker

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Plos Pathogens|December 7, 2016
C-type Lectin Mincle Recognizes Glucosyl-diacylglycerol of Streptococcus pneumoniae and Plays a Protective Role in Pneumococcal PneumoniaFriederike Behler-Janbeck, Tomotsugu Takano, Regina Maus, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Bioorganic & Medicinal Chemistry|April 6, 2010
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinonesBenjamin J Mulchin, Christopher G Newton, James W Baty, et al.
Journal of Pharmaceutical Sciences|May 8, 2013
Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8)Sook Wah Yee, Anh Nguyet Nguyen, Chaline Brown, et al.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Pharmacogenetics and Genomics|December 17, 2016
Characterization of ADME gene variation in 21 populations by exome sequencingDaniel H Hovelson, Zhengyu Xue, Matthew Zawistowski, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
British Journal of Clinical Pharmacology|August 15, 2025
Dose individualisation of antibiotics in critically ill patients with inflammation: A narrative reviewSarah Dräger, Iris K Minichmayr, Narges Alipanah-Lechner, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Plos Pathogens|December 7, 2016
C-type Lectin Mincle Recognizes Glucosyl-diacylglycerol of Streptococcus pneumoniae and Plays a Protective Role in Pneumococcal PneumoniaFriederike Behler-Janbeck, Tomotsugu Takano, Regina Maus, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Bioorganic & Medicinal Chemistry|April 6, 2010
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinonesBenjamin J Mulchin, Christopher G Newton, James W Baty, et al.
Journal of Pharmaceutical Sciences|May 8, 2013
Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8)Sook Wah Yee, Anh Nguyet Nguyen, Chaline Brown, et al.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Pharmacogenetics and Genomics|December 17, 2016
Characterization of ADME gene variation in 21 populations by exome sequencingDaniel H Hovelson, Zhengyu Xue, Matthew Zawistowski, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
British Journal of Clinical Pharmacology|August 15, 2025
Dose individualisation of antibiotics in critically ill patients with inflammation: A narrative reviewSarah Dräger, Iris K Minichmayr, Narges Alipanah-Lechner, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
Pageof 22